faz.net
🌐 85% Global Worthiness
GLP-1 Receptor Agonists: Significant Health Benefits and Risks Revealed in Large-Scale Study
A study of 1.4 million US veterans with type 2 diabetes revealed that GLP-1 receptor agonists, weekly-injected drugs, reduced the risk of 42 health issues, including cardiovascular problems and infections, but increased risks of gastrointestinal issues and low blood pressure.
GLP-1 Receptor Agonists: Significant Health Benefits and Risks Revealed in Large-Scale Study
A study of 1.4 million US veterans with type 2 diabetes revealed that GLP-1 receptor agonists, weekly-injected drugs, reduced the risk of 42 health issues, including cardiovascular problems and infections, but increased risks of gastrointestinal issues and low blood pressure.
Progress
40% Bias Score
Good Health and Well-being